665 related articles for article (PubMed ID: 33832602)
1. Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.
Pascual-Figal DA; Bayes-Genis A; Díez-Díez M; Hernández-Vicente Á; Vázquez-Andrés D; de la Barrera J; Vazquez E; Quintas A; Zuriaga MA; Asensio-López MC; Dopazo A; Sánchez-Cabo F; Fuster JJ
J Am Coll Cardiol; 2021 Apr; 77(14):1747-1759. PubMed ID: 33832602
[TBL] [Abstract][Full Text] [Related]
2. Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure.
Dorsheimer L; Assmus B; Rasper T; Ortmann CA; Ecke A; Abou-El-Ardat K; Schmid T; Brüne B; Wagner S; Serve H; Hoffmann J; Seeger F; Dimmeler S; Zeiher AM; Rieger MA
JAMA Cardiol; 2019 Jan; 4(1):25-33. PubMed ID: 30566180
[TBL] [Abstract][Full Text] [Related]
3. Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure.
Yu B; Roberts MB; Raffield LM; Zekavat SM; Nguyen NQH; Biggs ML; Brown MR; Griffin G; Desai P; Correa A; Morrison AC; Shah AM; Niroula A; Uddin MM; Honigberg MC; Ebert BL; Psaty BM; Whitsel EA; Manson JE; Kooperberg C; Bick AG; Ballantyne CM; Reiner AP; Natarajan P; Eaton CB;
J Am Coll Cardiol; 2021 Jul; 78(1):42-52. PubMed ID: 34210413
[TBL] [Abstract][Full Text] [Related]
4. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.
Abplanalp WT; Mas-Peiro S; Cremer S; John D; Dimmeler S; Zeiher AM
JAMA Cardiol; 2020 Oct; 5(10):1170-1175. PubMed ID: 32639511
[TBL] [Abstract][Full Text] [Related]
5. Clonal Hematopoiesis-Driver DNMT3A Mutations Alter Immune Cells in Heart Failure.
Abplanalp WT; Cremer S; John D; Hoffmann J; Schuhmacher B; Merten M; Rieger MA; Vasa-Nicotera M; Zeiher AM; Dimmeler S
Circ Res; 2021 Jan; 128(2):216-228. PubMed ID: 33155517
[TBL] [Abstract][Full Text] [Related]
6. Clonal Hematopoiesis and Incident Heart Failure With Preserved Ejection Fraction.
Schuermans A; Honigberg MC; Raffield LM; Yu B; Roberts MB; Kooperberg C; Desai P; Carson AP; Shah AM; Ballantyne CM; Bick AG; Natarajan P; Manson JE; Whitsel EA; Eaton CB; Reiner AP
JAMA Netw Open; 2024 Jan; 7(1):e2353244. PubMed ID: 38270950
[TBL] [Abstract][Full Text] [Related]
7. Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations.
Assmus B; Cremer S; Kirschbaum K; Culmann D; Kiefer K; Dorsheimer L; Rasper T; Abou-El-Ardat K; Herrmann E; Berkowitsch A; Hoffmann J; Seeger F; Mas-Peiro S; Rieger MA; Dimmeler S; Zeiher AM
Eur Heart J; 2021 Jan; 42(3):257-265. PubMed ID: 33241418
[TBL] [Abstract][Full Text] [Related]
8. Full spectrum of clonal haematopoiesis-driver mutations in chronic heart failure and their associations with mortality.
Kiefer KC; Cremer S; Pardali E; Assmus B; Abou-El-Ardat K; Kirschbaum K; Dorsheimer L; Rasper T; Berkowitsch A; Serve H; Dimmeler S; Zeiher AM; Rieger MA
ESC Heart Fail; 2021 Jun; 8(3):1873-1884. PubMed ID: 33779075
[TBL] [Abstract][Full Text] [Related]
9. Clonal hematopoiesis and associated diseases: A review of recent findings.
Asada S; Kitamura T
Cancer Sci; 2021 Oct; 112(10):3962-3971. PubMed ID: 34328684
[TBL] [Abstract][Full Text] [Related]
10. CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease.
Sano S; Oshima K; Wang Y; Katanasaka Y; Sano M; Walsh K
Circ Res; 2018 Jul; 123(3):335-341. PubMed ID: 29728415
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and prognostic significance of DNMT3A- and TET2- clonal haematopoiesis-driver mutations in patients presenting with ST-segment elevation myocardial infarction.
Wang S; Hu S; Luo X; Bao X; Li J; Liu M; Lv Y; Zhao C; Zeng M; Chen X; Unsworth A; Jones S; Johnson TW; White SJ; Jia H; Yu B
EBioMedicine; 2022 Apr; 78():103964. PubMed ID: 35339897
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations.
Calvillo-Argüelles O; Schoffel A; Capo-Chichi JM; Abdel-Qadir H; Schuh A; Carrillo-Estrada M; Liu S; Gupta V; Schimmer AD; Yee K; Shlush LI; Natarajan P; Thavendiranathan P
JACC CardioOncol; 2022 Mar; 4(1):38-49. PubMed ID: 35492819
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain).
Farré N; Lupon J; Roig E; Gonzalez-Costello J; Vila J; Perez S; de Antonio M; Solé-González E; Sánchez-Enrique C; Moliner P; Ruiz S; Enjuanes C; Mirabet S; Bayés-Genís A; Comin-Colet J;
BMJ Open; 2017 Dec; 7(12):e018719. PubMed ID: 29273666
[TBL] [Abstract][Full Text] [Related]
14. Clonal Hematopoiesis in Clinical and Experimental Heart Failure With Preserved Ejection Fraction.
Cochran JD; Yura Y; Thel MC; Doviak H; Polizio AH; Arai Y; Arai Y; Horitani K; Park E; Chavkin NW; Kour A; Sano S; Mahajan N; Evans M; Huba M; Naya NM; Sun H; Ban YH; Hirschi KK; Toldo S; Abbate A; Druley TE; Ruberg FL; Maurer MS; Ezekowitz JA; Dyck JRB; Walsh K
Circulation; 2023 Oct; 148(15):1165-1178. PubMed ID: 37681311
[TBL] [Abstract][Full Text] [Related]
15. Combined Effects of Clonal Hematopoiesis and Carotid Stenosis on Cardiovascular Mortality.
Jäger R; Hoke M; Mayer FJ; Boden S; Englisch C; Ay C; Kralovics R; Binder CJ
J Am Coll Cardiol; 2024 May; 83(18):1717-1727. PubMed ID: 38692825
[TBL] [Abstract][Full Text] [Related]
16. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
[TBL] [Abstract][Full Text] [Related]
17. Telomere Attrition and Clonal Hematopoiesis of Indeterminate Potential in Cardiovascular Disease.
Huang YC; Wang CY
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576030
[TBL] [Abstract][Full Text] [Related]
18. Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction: The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial.
Solomon SD; Claggett B; Desai AS; Packer M; Zile M; Swedberg K; Rouleau JL; Shi VC; Starling RC; Kozan Ö; Dukat A; Lefkowitz MP; McMurray JJ
Circ Heart Fail; 2016 Mar; 9(3):e002744. PubMed ID: 26915374
[TBL] [Abstract][Full Text] [Related]
19. Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study.
Ahn HJ; An HY; Ryu G; Lim J; Sun C; Song H; Choi SY; Lee H; Maurer T; Nachun D; Kwon S; Lee SR; Lip GYH; Oh S; Jaiswal S; Koh Y; Choi EK
Eur Heart J; 2024 Mar; 45(10):778-790. PubMed ID: 38231881
[TBL] [Abstract][Full Text] [Related]
20. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
